Literature DB >> 22908332

Fcγ receptors inhibit mouse and human basophil activation.

Lydie Cassard1, Friederike Jönsson, Ségolène Arnaud, Marc Daëron.   

Abstract

Besides high-affinity IgE receptors (FcεRI), human basophils express activating (FcγRIIA) and inhibitory (FcγRIIB) low-affinity IgG receptors. IgG receptors (FcγR) were also found on mouse basophils, but not identified. We investigated in this study FcγR and the biological consequences of their engagement in basophils of the two species. We found the following: (1) that mouse basophils also express activating (FcγRIIIA) and inhibitory (FcγRIIB) low-affinity FcγR; (2) that activating FcγR can activate both human and mouse basophils, albeit with different efficacies; (3) that negative signals triggered by inhibitory FcγR are dominant over positive signals triggered by activating FcγR, thus preventing both human and mouse basophils from being activated by IgG immune complexes; (4) that the coengagement of FcεRI with inhibitory and activating FcγR results in a FcγRIIB-dependent inhibition of IgE-induced responses of both human and mouse basophils; (5) that FcγRIIB has a similar dominant inhibitory effect in basophils from virtually all normal donors; and (6) that IL-3 upregulates the expression of both activating and inhibitory FcγR on human basophils from normal donors, but further enhances FcγRIIB-dependent inhibition. FcγR therefore function as a regulatory module, made of two subunits with antagonistic properties, that prevents IgG-induced and controls IgE-induced basophil activation in both mice and humans.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22908332     DOI: 10.4049/jimmunol.1200968

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  39 in total

1.  Lupus pathogenesis: role of IgE autoantibodies.

Authors:  Jagadeesh Bayry
Journal:  Cell Res       Date:  2016-01-22       Impact factor: 25.617

Review 2.  The deleterious role of basophils in systemic lupus erythematosus.

Authors:  Christophe Pellefigues; Nicolas Charles
Journal:  Curr Opin Immunol       Date:  2013-10-24       Impact factor: 7.486

3.  Autoantibodies to IgE and FcεRI and the natural variability of spleen tyrosine kinase expression in basophils.

Authors:  Donald MacGlashan
Journal:  J Allergy Clin Immunol       Date:  2018-06-01       Impact factor: 10.793

4.  Basophil-mediated protection against gastrointestinal helminths requires IgE-induced cytokine secretion.

Authors:  Christian Schwartz; Adriana Turqueti-Neves; Susanne Hartmann; Philipp Yu; Falk Nimmerjahn; David Voehringer
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-17       Impact factor: 11.205

5.  Autoimmunity: Basophils in autoimmune and inflammatory diseases.

Authors:  Meenu Sharma; Jagadeesh Bayry
Journal:  Nat Rev Rheumatol       Date:  2014-11-25       Impact factor: 20.543

6.  IgG subclasses determine pathways of anaphylaxis in mice.

Authors:  Héloïse Beutier; Caitlin M Gillis; Bruno Iannascoli; Ophélie Godon; Patrick England; Riccardo Sibilano; Laurent L Reber; Stephen J Galli; Mark S Cragg; Nico Van Rooijen; David A Mancardi; Pierre Bruhns; Friederike Jönsson
Journal:  J Allergy Clin Immunol       Date:  2016-04-26       Impact factor: 10.793

Review 7.  Fc receptors as adaptive immunoreceptors.

Authors:  Marc Daëron
Journal:  Curr Top Microbiol Immunol       Date:  2014       Impact factor: 4.291

Review 8.  Recent developments in understanding the mechanisms of food allergy.

Authors:  Zoe C Schmiechen; Katherine A Weissler; Pamela A Frischmeyer-Guerrerio
Journal:  Curr Opin Pediatr       Date:  2019-12       Impact factor: 2.856

Review 9.  Past, present, and future of anti-IgE biologics.

Authors:  Pascal Guntern; Alexander Eggel
Journal:  Allergy       Date:  2020-04-21       Impact factor: 13.146

10.  Parameters determining the efficacy of CD32 to inhibit activation of FcεRI in human basophils.

Authors:  Donald MacGlashan; Robert G Hamilton
Journal:  J Allergy Clin Immunol       Date:  2016-01-07       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.